With extensive experience in the chemistry sector, Andrew Mansfield specialises in flow chemistry, automation and enabling technologies. After earning a degree in Applied Chemistry, he worked with leading pharmaceutical companies including Roche, Pfizer, and Napp, focusing on high-throughput synthesis and process innovation. At Pfizer, he spearheaded the flow chemistry initiative, collaborating across research and process teams. He later ran a consultancy, guiding batch-to-flow transitions. In his current role at Asynt, he oversees research and development, product strategy and collaborative technical projects.